338 related articles for article (PubMed ID: 23965432)
21. Cytotoxic activities of recombinant immunotoxins composed of Pseudomonas toxin or diphtheria toxin toward lymphocytes from patients with adult T-cell leukemia.
Kreitman RJ; Chaudhary VK; Waldmann TA; Hanchard B; Cranston B; FitzGerald DJ; Pastan I
Leukemia; 1993 Apr; 7(4):553-62. PubMed ID: 8464234
[TBL] [Abstract][Full Text] [Related]
22. Diphtheria toxin-based targeted toxin therapy for brain tumors.
Li YM; Vallera DA; Hall WA
J Neurooncol; 2013 Sep; 114(2):155-64. PubMed ID: 23695514
[TBL] [Abstract][Full Text] [Related]
23. Immunotoxins for targeted cancer therapy.
Kreitman RJ
AAPS J; 2006 Aug; 8(3):E532-51. PubMed ID: 17025272
[TBL] [Abstract][Full Text] [Related]
24. Reasonable design of antibody mimetics for targeting glioma and small cell lung cancer.
Jiang T; Zhang L; Wang J; Li X
Eur J Cancer Prev; 2009 Nov; 18(6):431-5. PubMed ID: 19741543
[TBL] [Abstract][Full Text] [Related]
25. Novel genetic immunotoxins and intracellular antibodies for cancer therapy.
Chen SY; Marasco WA
Semin Oncol; 1996 Feb; 23(1):148-53. PubMed ID: 8607024
[TBL] [Abstract][Full Text] [Related]
26. Anthrax fusion protein therapy of cancer.
Frankel AE; Powell BL; Duesbery NS; Vande Woude GF; Leppla SH
Curr Protein Pept Sci; 2002 Aug; 3(4):399-407. PubMed ID: 12370003
[TBL] [Abstract][Full Text] [Related]
27. Receptor-directed chimeric toxins created by sortase-mediated protein fusion.
McCluskey AJ; Collier RJ
Mol Cancer Ther; 2013 Oct; 12(10):2273-81. PubMed ID: 23945077
[TBL] [Abstract][Full Text] [Related]
28. Clinical studies with targeted toxins in malignant glioma.
Rainov NG; Söling A
Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
[TBL] [Abstract][Full Text] [Related]
29. Immunotoxins.
Kreitman RJ
Expert Opin Pharmacother; 2000 Sep; 1(6):1117-29. PubMed ID: 11249483
[TBL] [Abstract][Full Text] [Related]
30. Recombinant toxins for the treatment of cancer.
Kreitman RJ
Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
[TBL] [Abstract][Full Text] [Related]
31. Effective targeted cytotoxicity of neuroblastoma cells.
Thomas PB; Delatte SJ; Sutphin A; Frankel AE; Tagge EP
J Pediatr Surg; 2002 Mar; 37(3):539-44. PubMed ID: 11877684
[TBL] [Abstract][Full Text] [Related]
32. Recombinant immunotoxins for treating cancer.
FitzGerald DJ; Kreitman R; Wilson W; Squires D; Pastan I
Int J Med Microbiol; 2004 Apr; 293(7-8):577-82. PubMed ID: 15149034
[TBL] [Abstract][Full Text] [Related]
33. Toxin conjugate therapy of cancer.
Wong L; Suh DY; Frankel AE
Semin Oncol; 2005 Dec; 32(6):591-5. PubMed ID: 16338425
[TBL] [Abstract][Full Text] [Related]
34. Recombinant immunotoxins for cancer therapy.
Brinkmann U; Keppler-Hafkemeyer A; Hafkemeyer P
Expert Opin Biol Ther; 2001 Jul; 1(4):693-702. PubMed ID: 11727505
[TBL] [Abstract][Full Text] [Related]
35. Specific targeting to murine myeloma cells of Cyt1Aa toxin from Bacillus thuringiensis subspecies israelensis.
Cohen S; Cahan R; Ben-Dov E; Nisnevitch M; Zaritsky A; Firer MA
J Biol Chem; 2007 Sep; 282(39):28301-28308. PubMed ID: 17626007
[TBL] [Abstract][Full Text] [Related]
36. Recombinant immunotoxins for the treatment of haematological malignancies.
Kreitman RJ
Expert Opin Biol Ther; 2004 Jul; 4(7):1115-28. PubMed ID: 15268678
[TBL] [Abstract][Full Text] [Related]
37. Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS.
Vitetta ES
J Clin Immunol; 1990 Nov; 10(6 Suppl):15S-18S. PubMed ID: 2081785
[TBL] [Abstract][Full Text] [Related]
38. [Immunotoxins].
Gedikoğlu S
Mikrobiyol Bul; 1990 Jan; 24(1):79-87. PubMed ID: 2283968
[TBL] [Abstract][Full Text] [Related]
39. Targeted toxins as anticancer agents.
Siegall CB
Cancer; 1994 Aug; 74(3 Suppl):1006-12. PubMed ID: 7913661
[TBL] [Abstract][Full Text] [Related]
40. Novel therapeutic strategies to selectively kill cancer cells.
Panchal RG
Biochem Pharmacol; 1998 Feb; 55(3):247-52. PubMed ID: 9484789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
